These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
493 related articles for article (PubMed ID: 31089878)
1. Significant reduction in the expression of interleukins-17A, 22 and 23A, forkhead box p3 and interferon gamma delineates lichen planus pigmentosus from lichen planus. Kumaran MS; Bishnoi A; Srivastava N; Tekumalla S; Vinay K; Bhatia A; Parsad D Arch Dermatol Res; 2019 Sep; 311(7):519-527. PubMed ID: 31089878 [TBL] [Abstract][Full Text] [Related]
2. Frequently Increased but Functionally Impaired CD4+CD25+ Regulatory T Cells in Patients with Oral Lichen Planus. Zhou L; Cao T; Wang Y; Yao H; Du G; Chen G; Niu X; Tang G Inflammation; 2016 Jun; 39(3):1205-15. PubMed ID: 27106476 [TBL] [Abstract][Full Text] [Related]
3. Expression of Foxp3 and interleukin-17 in lichen planus lesions with emphasis on difference in oral and cutaneous variants. Shen Z; Gao X; Ma L; Zhou Z; Shen X; Liu W Arch Dermatol Res; 2014 Jul; 306(5):441-6. PubMed ID: 24292092 [TBL] [Abstract][Full Text] [Related]
4. The inflammation in cutaneous lichen planus is dominated by IFN-ϒ and IL-21-A basis for therapeutic JAK1 inhibition. Pietschke K; Holstein J; Meier K; Schäfer I; Müller-Hermelink E; Gonzalez-Menendez I; Quintanilla-Martinez L; Ghoreschi FC; Solimani F; Ghoreschi K Exp Dermatol; 2021 Feb; 30(2):262-270. PubMed ID: 33113249 [TBL] [Abstract][Full Text] [Related]
6. Distinct interferon-gamma and interleukin-9 expression in cutaneous and oral lichen planus. Weber B; Schlapbach C; Stuck M; Simon HU; Borradori L; Beltraminelli H; Simon D J Eur Acad Dermatol Venereol; 2017 May; 31(5):880-886. PubMed ID: 27696572 [TBL] [Abstract][Full Text] [Related]
7. Reduced immune responses to purified protein derivative and Candida albicans in oral lichen planus. Simark-Mattsson C; Eklund C J Oral Pathol Med; 2013 Oct; 42(9):691-7. PubMed ID: 23607487 [TBL] [Abstract][Full Text] [Related]
8. Systematic Review of Lichen Planus Pigmentosus in Children. Mitchell K; Silverberg N J Drugs Dermatol; 2022 Aug; 21(8):850-853. PubMed ID: 35946962 [TBL] [Abstract][Full Text] [Related]
9. Ocular involvement and complications of lichen planus, lichen planus pigmentosus, and lichen planopilaris: A comprehensive review. Ruiz-Lozano RE; Hernández-Camarena JC; Valdez-Garcia JE; Roman-Zamudio M; Herrera-Rodriguez MI; Andrade-Carrillo D; Garza-Garza LA; Cardenas-de la Garza JA Dermatol Ther; 2021 Nov; 34(6):e15137. PubMed ID: 34541780 [TBL] [Abstract][Full Text] [Related]
10. Secukinumab in adult patients with lichen planus: efficacy and safety results from the randomized placebo-controlled proof-of-concept PRELUDE study. Passeron T; Reinhardt M; Ehst B; Weiss J; Sluzevich J; Sticherling M; Reygagne P; Wohlrab J; Hertl M; Fazel N; Muscianisi E; Fan H; Hampele I; Compagno N Br J Dermatol; 2024 Oct; 191(5):680-690. PubMed ID: 38735684 [TBL] [Abstract][Full Text] [Related]
11. Deregulation of circ_003912 contributes to pathogenesis of erosive oral lichen planus by via sponging microRNA-123, -647 and -31 and upregulating FOXP3. Huang Z; Liu F; Wang W; Ouyang S; Sang T; Huang Z; Liao L; Wu J Mol Med; 2021 Oct; 27(1):132. PubMed ID: 34670484 [TBL] [Abstract][Full Text] [Related]
12. [Effects of interleukin-35 on the balance of helper T cell 17/regulatory T cell in peripheral blood of patients with oral lichen planus]. Hu WY; Huang YY; Liu T; Cai Y Zhonghua Kou Qiang Yi Xue Za Zhi; 2020 Feb; 55(2):80-85. PubMed ID: 32074667 [No Abstract] [Full Text] [Related]
13. Subcutaneous administration of polymerized type I collagen downregulates interleukin (IL)-17A, IL-22 and transforming growth factor-β1 expression, and increases Foxp3-expressing cells in localized scleroderma. Furuzawa-Carballeda J; Ortíz-Ávalos M; Lima G; Jurado-Santa Cruz F; Llorente L Clin Exp Dermatol; 2012 Aug; 37(6):599-609. PubMed ID: 22731679 [TBL] [Abstract][Full Text] [Related]
14. Potential pathogenetic role of Th17, Th0, and Th2 cells in erosive and reticular oral lichen planus. Piccinni MP; Lombardelli L; Logiodice F; Tesi D; Kullolli O; Biagiotti R; Giudizi M; Romagnani S; Maggi E; Ficarra G Oral Dis; 2014 Mar; 20(2):212-8. PubMed ID: 23556506 [TBL] [Abstract][Full Text] [Related]
15. T lymphocytes and altered keratinocytes express interferon-gamma and interleukin 6 in lichen planus. Fayyazi A; Schweyer S; Soruri A; Duong LQ; Radzun HJ; Peters J; Parwaresch R; Berger H Arch Dermatol Res; 1999 Sep; 291(9):485-90. PubMed ID: 10541878 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of correlation between transcription factors and IL-17 in oral and cutaneous lichen planus lesions and Leukocytes. Zare R; Mohtasham N; Ghazi N; Mosannen Mozafari P; Abdollahpoor M; Poursheikhani A; Mohajertehran F; Esmaeilzadeh A Cytokine; 2021 Dec; 148():155696. PubMed ID: 34509039 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic Targeting of Th17/Tc17 Cells Leads to Clinical Improvement of Lichen Planus. Solimani F; Pollmann R; Schmidt T; Schmidt A; Zheng X; Savai R; Mühlenbein S; Pickert J; Eubel V; Möbs C; Eming R; Hertl M Front Immunol; 2019; 10():1808. PubMed ID: 31417572 [TBL] [Abstract][Full Text] [Related]
18. Case of lichen planus pigmentosus with unique distribution. Takeoka S; Tada Y; Ohnishi T; Watanabe S J Dermatol; 2015 Jun; 42(6):652-4. PubMed ID: 25808218 [No Abstract] [Full Text] [Related]
19. Lichen planus: altered AIM2 and NLRP1 expression in skin lesions and defective activation in peripheral blood mononuclear cells. Domingues R; Pietrobon AJ; Carvalho GC; Pereira NZ; Pereira NV; Sotto MN; Aoki V; Duarte AJS; Sato MN Clin Exp Dermatol; 2019 Jun; 44(4):e89-e95. PubMed ID: 30552699 [TBL] [Abstract][Full Text] [Related]
20. Cytokines Levels and Salivary Microbiome Play A Potential Role in Oral Lichen Planus Diagnosis. Carvalho MFMS; Cavalieri D; Do Nascimento S; Lourenço TGB; Ramos DVR; Pasqualin DDC; Martins LAL; Rocha FA; Heller D; Marti L Sci Rep; 2019 Dec; 9(1):18137. PubMed ID: 31792433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]